Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth

 Published On: Jul, 2011 |  Published By: GBI Research | Format: PDF
Request Free Sample Share on Whatsapp

“Neurology Devices Market to 2017- High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth” provides key data, information and analysis on the global neurology devices market. The report provides market landscape, competitive landscape and market trends information on five neurology devices market categories – CSF management, neurosurgical products, neurostimulation devices, interventional neurology, and neurological diagnostic equipment. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape and a detailed analysis of the pipeline products in each category. The report also reviews details about important merger and acquisition deals that have taken place in the neurology devices market during the past four years. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

  • Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
  • Market size and company share data for five neurology devices market categories – CSF management, neurosurgical products, neurostimulation devices, interventional neurology, and neurological diagnostic equipment.
  • Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2010 has been given for all categories.
  • Qualitative analysis of key market trends, market drivers, and restraints by each category within the endoscopy devices market.
  • The report also covers information on the leading market players, the competitive landscape, and the leading technologies.
  • Key players covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Inc, Integra LifeSciences Holdings Corporation, B. Braun Melsungen AG and Cadwell Laboratories, Inc.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments that are driving the neurology devices market globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • What’s the next being thing in the neurology devices market landscape? – Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global neurology devices market and the factors shaping it.


1 Table Of Contents 2

1.1 List of Tables 8

1.2 List of Figures 10

2 Executive Summary 13

2.1 Global Neurology Devices Market is Forecast to Reach $7.2 Billion by 2017 13

2.2 Medtronic was the Leading Company in the Global Neurology Devices Market in 2010 14

2.3 The US was the Biggest Market for Neurology Devices in 2010 16

2.4 Neurostimulation Devices to Continue to be the Largest Category in the Global Neurology Device Market in 2010 17

3 Introduction 18

3.1 GBI Research Guidance 18

4 Global Neurology Devices Market Characterization 20

4.1 Global Neurology Devices Market, Revenue ($m), 2003–2010 20

4.2 Global Neurology Devices Market, Revenue Forecast ($m), 2010–2017 21

4.3 Global Neurology Devices Market, Key Trends 23

4.3.1 Neurostimulation Devices Segment Holds Significant Potential for Venture Capitalists 23

4.3.1.1 Imthera Medial Raises an Additional $0.4m in Venture Financing Round 24

4.3.1.2 MindFrame Secures $3.6m in Financing Round 24

4.3.2 Innovative Therapies to be a Mainstay in the Neurology Devices Market 24

4.3.3 Robotic Neurosurgery is Improving Accuracy at a Microscopic Level 25

4.3.4 Increasing Demand for Minimally Invasive Surgery is Positively Impacting the Interventional Neurology Market 26

4.4 Global Neurology Devices Market, Market Dynamics 27

4.4.1 Market Drivers 27

4.4.1.1 Multiple Indication Potential of Neurology Devices Will Drive Market Growth 27

4.4.1.2 Extensive Marketing Strategies Followed by Neurology Devices Companies will help to Increase Market Share 28

4.4.1.3 Improved Accuracy and Visualization in the Operating Room will Increase Surgeon Adoption Rates for Neurology Devices 28

4.4.2 Market Restraints 29

4.4.2.1 Reduction in Medicare Payments for Neurosurgeons to Affect Patients’ Access to Care Limiting Neurology Devices Market Growth 29

4.4.2.2 High Market Entry Barriers and Government Regulations Restrict Entry for New Players Limiting Market Growth 30

4.4.2.3 High Cost of Devices Acts as a Barrier for Neurology Devices Market Growth 30

4.5 Global Neurology Devices Market, Key Company Share (%), 2010 31

5 Global Neurology Devices Market: Category Analysis and Forecasts 34

5.1 Neurology Devices 34

5.2 CSF Management 35

5.2.1 CSF Management Market, Global, Revenue ($m), 2003–2010 35

5.2.2 CSF Management Market, Global, Revenue Forecast ($m), 2010–2017 37

5.2.3 CSF Management: Market Dynamics 38

5.2.4 Market Drivers 39

5.2.4.1 Increased Awareness of Neurological Disorders and Advanced Products will Propel CSF Management Market Growth 39

5.2.4.2 Increase in Number of Hydrocephalus Cases to Drive the Market in the Future 40

5.2.5 Market Restraints 40

5.2.5.1 Complications Associated with Hydrocephalus Shunting to Impact Market Growth 40

5.2.5.2 Lack of Specialized Training for Neurology Procedures among Surgeons to Limit Treatment Options, thereby Reducing CSF Management Market Growth 41

5.2.6 CSF Management Market, Global, Company Share (%), 2010 41

5.3 Neurosurgical Products 43

5.3.1 Neurosurgical Products Market, Global, Revenue ($m), 2003–2010 44

5.3.2 Neurosurgical Products Market, Global, Revenue Forecast ($m), 2010–2017 45

5.3.3 Neurosurgical Products Market Dynamics 47

5.3.4 Market Drivers 47

5.3.4.1 Growing Demand for Minimally Invasive Procedures to Drive Growth in the Neurosurgical Products Market 47

5.3.4.2 Neuroendoscope Market is Expected to Witness Healthy Growth in the Future Owing to Increased Demand from Pediatric Neurosurgery 48

5.3.5 Market Restraints 49

5.3.5.1 Complications and Technical Difficulties in Performing the Procedure and Advent of Ventricular Shunts is Slowing the Neurosurgical Products Market Growth 49

5.3.6 Neurosurgical Products Market, Global, Company Share (%), 2010 49

5.4 Neurostimulation Devices 51

5.4.1 Neurostimulation Devices Market, Global, Revenue ($m), 2003–2010 52

5.4.2 Neurostimulation Devices Market, Global, Revenue Forecasts ($m), 2010–2017 53

5.4.3 Neurostimulation Devices Market Dynamics 55

5.4.4 Market Drivers 55

5.4.4.1 Neurostimulation Devices Offers Multi-Indication Potential to Treat Neurological Disorders Giving a Boost to Market Growth 56

5.4.4.2 High Prevalence and Incidence of Neurological Disorders to Drive Market Growth in the Future 57

5.4.4.3 Robust Pipeline in Neurostimulation Devices is Expected to Bring New Products and Drive the Market Growth 57

5.4.4.4 Neurostimulation Devices a more Effective Mode of Treatment for Neurological Disorders than Drugs 59

5.4.4.5 Better Outcomes of Neurostimulation Devices Leading to an Increase in Neurosurgeon Adoption Rates 59

5.4.4.6 Technological Advancements in the Treatment of Parkinson’s Disease and the Growing Demand for Alternative Therapies Enhancing Prospects in the Neurostimulation Device Market 60

5.4.4.7 Clinical Data Proving the Efficacy of Neurostimulation Therapy for Chronic Neuropathic Leg and Back Pain Favoring Market Growth 61

5.4.5 Market Restraints 61

5.4.5.1 High Cost of Treatment and Lack of Awareness Among the Patient Population about Alternative Treatment Options of Pain is a Major Restraining Factor for Market Growth 61

5.4.5.2 Lack of Skilled Neurosurgeons in Emerging Countries such as India, China and Brazil Reducing Prescription Rates 62

5.4.6 Neurostimulation Device Market, Global, Company Shares (%), 2010 62

5.5 Interventional Neurology 64

5.5.1 Interventional Neurology Market, Global, Revenue ($m), 2003–2010 65

5.5.2 Interventional Neurology Market, Global, Revenue Forecasts ($m), 2010–2017 67

5.5.3 Interventional Neurology: Market Dynamics 69

5.5.4 Market Drivers 70

5.5.4.1 Increase in Prevalence of Neurovascular Diseased Population to Drive the Interventional Neurology Market 70

5.5.4.2 Increased Safety and Effectiveness Due to Technological Advancements in Embolic System for Treating Cerebral Aneurysms Has Reduced Recurrence and Retreatment Rates 71

5.5.5 Market Restraints 71

5.5.5.1 Shortage of Neurosurgeons Trained to use Aneurysm Prevention Devices and Advanced Stroke Limits the Availability of Treatment Options 71

5.5.6 Interventional Neurology Market, Global, Company Shares (%), 2010 71

5.6 Neurological Diagnostic Equipment 73

5.6.1 Neurological Diagnostic Equipment Market, Global, Revenue ($m), 2003–2010 73

5.6.2 Neurological Diagnostic Equipment Market, Global, Revenue Forecasts ($m), 2010–2017 75

5.6.3 Neurological Diagnostic Equipment: Market Dynamics 77

5.6.4 Market Drivers 77

5.6.4.1 Advancements in Electroencephalography (EEG) Equipment Technology will Drive Future Growth in the Neurological Diagnostic Equipment Market 78

5.6.4.2 Rising Number of Physicians’ Offices Leading to Additional Sale of EEG and EMG Monitoring Devices 78

5.6.4.3 Rising Incidence of Neurological Disorders Resulting in Significant Growth of the Neurological Diagnostic Equipment Market 78

5.6.5 Market Restraints 79

5.6.5.1 Complications Related to the Usage of ICP Monitoring Devices has Limited the Market Growth of Neurological Diagnostic Equipment 79

5.6.5.2 Healthcare Reforms and Cost Containment Measures by Hospitals to Reduce Demand for Neurological Diagnostic Equipment 80

5.6.6 Neurological Diagnostic Equipment Market, Global, Company Shares (%), 2010 80

6 Global Neurology Devices Market: Country Analysis and Forecasts 83

6.1 Neurology Devices Market: Cross Country Analysis 83

6.2 Revenue Forecasts, By Country, 2003-2017 84

6.2.1 Neurology Devices Market, US, Revenue ($m), 2003–2010 84

6.2.2 Neurology Devices Market, US, Revenue ($m), 2010–2017 86

6.2.3 Neurology Devices Market, Canada, Revenue ($m), 2003–2010 88

6.2.4 Neurology Devices Market, Canada, Revenue ($m), 2010–2017 90

6.2.5 Neurology Devices Market, UK, Revenue ($m), 2003–2010 92

6.2.6 Neurology Devices Market, UK, Revenue ($m), 2010–2017 94

6.2.7 Neurology Devices Market, Germany, Revenue ($m), 2003–2010 95

6.2.8 Neurology Devices Market, Germany, Revenue ($m), 2010–2017 97

6.2.9 Neurology Devices Market, France, Revenue ($m), 2003–2010 99

6.2.10 Neurology Devices Market, France, Revenue ($m), 2010–2017 101

6.2.11 Neurology Devices Market, Italy, Revenue ($m), 2003–2010 102

6.2.12 Neurology Devices Market, Italy, Revenue ($m), 2010–2017 104

6.2.13 Neurology Devices Market, Spain, Revenue ($m), 2003–2010 106

6.2.14 Neurology Devices Market, Spain, Revenue ($m), 2010–2017 107

6.2.15 Neurology Devices Market, Japan, Revenue ($m), 2003–2010 109

6.2.16 Neurology Devices Market, Japan, Revenue ($m), 2010–2017 111

6.2.17 Neurology Devices Market, China, Revenue ($m), 2003–2010 113

6.2.18 Neurology Devices Market, China, Revenue ($m), 2010–2017 115

6.2.19 Neurology Devices Market, India, Revenue ($m), 2003–2010 116

6.2.20 Neurology Devices Market, India, Revenue ($m), 2010–2017 118

6.2.21 Neurology Devices Market, Australia, Revenue ($m), 2003–2010 119

6.2.22 Neurology Devices Market, Australia, Revenue ($m), 2010–2017 121

6.2.23 Neurology Devices Market, Brazil, Revenue ($m), 2003–2010 122

6.2.24 Neurology Devices Market, Brazil, Revenue ($m), 2010–2017 124

7 Global Neurology Devices Market: Competitive Assessment 126

7.1 Neurology Devices Market Opportunities and Risk Evaluation 126

7.2 Medtronic, Inc. 129

7.2.1 Business Overview 130

7.2.2 Key Products 130

7.3 Boston Scientific Corporation 133

7.3.1 Business Overview 133

7.3.2 Key Products 133

7.4 St. Jude Medical, Inc 135

7.4.1 Business Overview 136

7.4.2 Key Products 136

7.5 Integra LifeSciences Holdings Corporation 137

7.5.1 Business Overview 138

7.5.2 Key Products 138

7.6 B. Braun Melsungen AG 141

7.6.1 Business Overview 142

7.7 Cadwell Laboratories, Inc. 143

7.7.1 Business Overview 143

7.7.2 Key Products 144

8 Global Neurology Devices Market: Product Pipeline Analysis 147

8.1 Neurology Devices: Pipeline Products Summary 147

8.2 Neurostimulation Devices 148

8.2.1 Neurostimulation Devices: List of Pipeline Products 148

8.2.2 Neurostimulation Devices: Profiles of Key Pipeline Products 153

8.2.2.1 Vagus Nerve Stimulators 153

8.2.2.2 Deep Brain Stimulators 154

8.2.2.3 Spinal Cord Stimulators 155

8.2.2.4 Sacral Nerve Stimulators 155

8.2.2.5 Other Neurostimulation Devices 156

8.3 Interventional Neurology 156

8.3.1 Interventional Neurology: List of Pipeline Products 156

8.3.2 Interventional Neurology: Profiles of Key Pipeline Products 158

8.3.2.1 Embolic Systems 158

8.3.2.2 Navigational Systems 159

8.3.2.3 Other Interventional Neurology Devices 159

8.4 Neurological Diagnostic Equipment 160

8.4.1 Neurological Diagnostic Equipment: List of Pipeline Products 160

8.4.2 Neurological Diagnostic Equipment: Profiles of Key Pipeline Products 162

8.5 Neurosurgical Products 163

8.5.1 Neurosurgical Products: List of Pipeline Products 163

8.5.2 Neurosurgical Products: Profiles of Key Pipeline Products 164

8.6 CSF Management 165

8.6.1 CSF Management: List of Pipeline Products 165

8.6.2 CSF Management: Profiles of Key Pipeline Products 165

9 Global Neurology Device Market: Consolidation Landscape 167

9.1 Deals by Count, 2007-2010 167

9.2 Key Deals in 2007-2010 170

9.2.1 Johnson & Johnson Completes Acquisition of Micrus Endovascular 170

9.2.1.1 Deal Rationale 170

9.2.1.2 Company Overview 171

9.2.2 Covidien Completes Acquisition Of ev3 for $2.6 Billion 171

9.2.2.1 Deal Rationale 172

9.2.2.2 Company Overview 172

9.2.3 Medtronic Acquired NDI Medical 172

9.2.3.1 Deal Rationale 172

9.2.3.2 Company Overview 173

10 Appendix 174

10.1 Definitions 174

10.1.1 Neurology Devices 174

10.1.2 CSF Management 174

10.1.2.1 Dura Substitutes 174

10.1.2.2 Hydrocephalus Shunts 174

10.1.3 Interventional Neurology 174

10.1.3.1 Aneurysm Clips 174

10.1.3.2 Embolic Systems 174

10.1.3.3 Navigational Systems 175

10.1.3.4 Neurovascular Stents 175

10.1.4 Neurological Diagnostic Equipment 175

10.1.4.1 Electroencephelograms (EEG) 175

10.1.4.2 Electromyograms (EMG) 175

10.1.4.3 ICP Monitoring Devices 176

10.1.5 Neurostimulation Devices 176

10.1.5.1 Cortical Stimulator 176

10.1.5.2 Deep Brain Stimulators 176

10.1.5.3 Sacral Nerve Stimulator 176

10.1.5.4 Spinal Cord Stimulators 176

10.1.5.5 Vagus Nerve Stimulators 176

10.1.6 Neurosurgical Products 177

10.1.6.1 Neuroendoscopes 177

10.1.6.2 Neurosurgical Drills 177

10.2 Sources 177

10.3 Acronyms 177

10.4 Research Methodology 178

10.4.1 Secondary Research 179

10.4.2 Primary Research 179

10.4.3 Modeling and Forecasting 180

10.5 Contact Us 180

10.6 Disclaimer 180

List of Figures

Figure 1: Neurology Devices Market, Global, Overall Revenues ($bn), 2010–2017 13

Figure 2: Neurology Devices Market, Global, Company Share (%), 2010 15

Figure 3: Neurology Devices Market, Global ,Geographic Contribution (%), 2010 16

Figure 4: Neurology Devices Market, Global, Revenue ($m), 2003–2010 20

Figure 5: Neurology Devices Market, Global, Revenue ($m), 2010–2017 22

Figure 6: Neurology Devices Market Dynamics 27

Figure 7: Neurology Device Market, Global, Company Share (%), 2010 32

Figure 8: Neurology Devices Market Categorization and Segmentation 34

Figure 9: CSF Management Market, Global, Revenue ($m), 2003–2010 36

Figure 10: CSF Management Market, Global, Revenue ($m), 2010–2017 37

Figure 11: CSF Management, Market Dynamics 39

Figure 12: CSF Management Market, Global, Company Share (%), 2010 42

Figure 13: Neurosurgical Products Market, Global, Revenue ($m), 2003–2010 44

Figure 14: Neurosurgical Products Market, Global, Revenue ($m), 2010–2017 46

Figure 15: Neurosurgical Products Market Dynamics 47

Figure 16: Neurosurgical Products Market, Global, Company Share (%), 2010 50

Figure 17: Neurostimulation Devices Market, Global, Revenue ($m), 2003–2010 52

Figure 18: Neurostimulation Devices Market, Global, Revenue ($m), 2010–2017 54

Figure 19: Neurostimulation Devices Market Dynamics 55

Figure 20: Potential of Neurostimulation Devices for the Treatment of Various Indications, 2010 56

Figure 21: Neurology Devices, Global, Number of Pipeline Products, 2011 58

Figure 22: Neurostimulation Devices Market, Global, Company Shares (%), 2010 63

Figure 23: Interventional Neurology Market, Global, Revenue ($m), 2003–2010 66

Figure 24: Interventional Neurology Market, Global, Revenue ($m), 2010–2017 68

Figure 25: Interventional Neurology, Market Dynamics 70

Figure 26: Interventional Neurology Market, Global, Company Shares (%), 2010 72

Figure 27: Neurological Diagnostic Equipment Market, Global, Revenue ($m), 2003–2010 74

Figure 28: Neurological Diagnostic Equipment Market, Global, Revenue ($m), 2010–2017 76

Figure 29: Neurological Diagnostic Equipment, Market Dynamics 77

Figure 30: Neurological Diagnostic Equipment Market, Global, Company Shares (%), 2010 81

Figure 31: Neurology Devices Market, Cross Country Analysis, Global, CAGR (%), 2003–2017 83

Figure 32: Neurology Devices Market, US, Revenue ($m), 2003–2010 85

Figure 33: Neurology Devices Market, US, Revenue ($m), 2010–2017 87

Figure 34: Neurology Devices Market, Canada, Revenue ($m), 2003–2010 89

Figure 35: Neurology Devices Market, Canada, Revenue ($m), 2010–2017 91

Figure 36: Neurology Devices Market, UK, Revenue ($m), 2003–2010 93

Figure 37: Neurology Devices Market, UK, Revenue ($m), 2010–2017 94

Figure 38: Neurology Devices Market, Germany, Revenue ($m), 2003–2010 96

Figure 39: Neurology Devices Market, Germany, Revenue ($m), 2010–2017 98

Figure 40: Neurology Devices Market, France, Revenue ($m), 2003–2010 100

Figure 41: Neurology Devices Market, France, Revenue ($m), 2010–2017 101

Figure 42: Neurology Devices Market, Italy, Revenue ($m), 2003–2010 103

Figure 43: Neurology Devices Market, Italy, Revenue ($m), 2010–2017 105

Figure 44: Neurology Devices Market, Spain, Revenue ($m), 2003–2010 106

Figure 45: Neurology Devices Market, Spain, Revenue ($m), 2010–2017 108

Figure 46: Neurology Devices Market, Japan, Revenue ($m), 2003–2010 110

Figure 47: Neurology Devices Market, Japan, Revenue ($m), 2010–2017 112

Figure 48: Neurology Devices Market, China, Revenue ($m), 2003–2010 114

Figure 49: Neurology Devices Market, China, Revenue ($m), 2010–2017 115

Figure 50: Neurology Devices Market, India, Revenue ($m), 2003–2010 117

Figure 51: Neurology Devices Market, India, Revenue ($m), 2010–2017 118

Figure 52: Neurology Devices Market, Australia, Revenue ($m), 2003–2010 120

Figure 53: Neurology Devices Market, Australia, Revenue ($m), 2010–2017 121

Figure 54: Neurology Devices Market, Brazil, Revenue ($m), 2003–2010 123

Figure 55: Neurology Devices Market, Brazil, Revenue ($m), 2010–2017 124

Figure 56: Neurology Devices Market Opportunities and Risk Evaluation, Global, by Segment 126

Figure 57: Neurology Devices, Competitive Assessment, 2011 129

Figure 58: Medtronic, Inc, SWOT Analysis, Neurology Devices, Global, 2010 132

Figure 59:Boston Scientific Corporation, SWOT Analysis, Neurology Devices, Global, 2010 135

Figure 60: St. Jude Medical, Inc, SWOT Analysis, Neurology Devices, Global, 2010 137

Figure 61: Integra LifeSciences Holdings Corporation, SWOT Analysis, Neurology Devices, Global, 2010 141

Figure 62: B. Braun Melsungen AG, SWOT Analysis, Neurology Devices, Global, 2010 143

Figure 63: Cadwell Laboratories, Inc, SWOT Analysis, Neurology Devices, Global, 2010 146

Figure 64: Neurology Devices: Pipeline Products Summary, 2011 147

Figure 65: Neurology Device Market, Mergers & Acquisitions, by Volume, Global, 2007-2010 167

List of Tables

Table 1: Neurology Devices Market, Global, Revenue ($m), 2003–2010 21

Table 2: Neurology Devices Market, Global, Revenue ($m), 2010–2017 23

Table 3: Neurology Device Market, Global, Key Company Revenues ($m), 2010 33

Table 4: CSF Management Market, Global, Revenue ($m), 2003–2010 36

Table 5: CSF Management Market, Global, Revenue ($m), 2010–2017 38

Table 6: CSF Management Market, Global, Key Company Revenues ($m), 2010 43

Table 7: Neurosurgical Products Market, Global, Revenue ($m), 2003–2010 45

Table 8: Neurosurgical Products Market, Global, Revenue ($m), 2010–2017 46

Table 9: Neurosurgical Products Market, Global, Key Company Revenues ($m), 2010 50

Table 10: Neurostimulation Devices Market, Global, Revenue ($m), 2003–2010 53

Table 11: Neurostimulation Devices Market, Global, Revenue ($m), 2010–2017 54

Table 12: Neurostimulation Devices Market, Global, Key Company Revenues ($m), 2010 64

Table 13: Interventional Neurology Market, Global, Revenue ($m), 2003–2010 67

Table 14: Interventional Neurology Market, Global, Revenue ($m), 2010–2017 69

Table 15: Interventional Neurology Market, Global, Key Company Revenues ($m), 2010 73

Table 16: Neurological Diagnostic Equipment Market, Global, Revenue ($m), 2003–2010 75

Table 17: Neurological Diagnostic Equipment Market, Global, Revenue ($m), 2010–2017 76

Table 18: Neurological Diagnostic Equipment Market, Global, Key Company Revenues ($m), 2010 82

Table 19: Neurology Devices Market, Cross Country Analysis, Global, CAGR (%), 2003–2017 84

Table 20: Neurology Devices Market, US, Revenue ($m), 2003–2010 86

Table 21: Neurology Devices Market, US, Revenue ($m), 2010–2017 88

Table 22: Neurology Devices Market, Canada, Revenue ($m), 2003–2010 90

Table 23: Neurology Devices Market, Canada, Revenue ($m), 2010–2017 92

Table 24: Neurology Devices Market, UK, Revenue ($m), 2003–2010 93

Table 25: Neurology Devices Market, UK, Revenue ($m), 2010–2017 95

Table 26: Neurology Devices Market, Germany, Revenue ($m), 2003–2010 97

Table 27: Neurology Devices Market, Germany, Revenue ($m), 2010–2017 99

Table 28: Neurology Devices Market, France, Revenue ($m), 2003–2010 100

Table 29: Neurology Devices Market, France, Revenue ($m), 2010–2017 102

Table 30: Neurology Devices Market, Italy, Revenue ($m), 2003–2010 104

Table 31: Neurology Devices Market, Italy, Revenue ($m), 2010–2017 105

Table 32: Neurology Devices Market, Spain, Revenue ($m), 2003–2010 107

Table 33: Neurology Devices Market, Spain, Revenue ($m), 2010–2017 109

Table 34: Neurology Devices Market, Japan, Revenue ($m), 2003–2010 111

Table 35: Neurology Devices Market, Japan, Revenue ($m), 2010–2017 112

Table 36: Neurology Devices Market, China, Revenue ($m), 2003–2010 114

Table 37: Neurology Devices Market, China, Revenue ($m), 2010–2017 116

Table 38: Neurology Devices Market, India, Revenue ($m), 2003–2010 117

Table 39: Neurology Devices Market, India, Revenue ($m), 2010–2017 119

Table 40: Neurology Devices Market, Australia, Revenue ($m), 2003–2010 120

Table 41: Neurology Devices Market, Australia, Revenue ($m), 2010–2017 122

Table 42: Neurology Devices Market, Brazil, Revenue ($m), 2003–2010 123

Table 43: Neurology Devices Market, Brazil, Revenue ($m), 2010–2017 125

Table 44: Neurology Devices: Pipeline Products Summary, 2011 148

Table 45: Neurostimulation Devices: List of Pipeline Products-1, 2011 149

Table 45: Neurostimulation Devices: List of Pipeline Products-2, 2011 150

Table 45: Neurostimulation Devices: List of Pipeline Products-3, 2011 151

Table 45: Neurostimulation Devices: List of Pipeline Products-4, 2011 152

Table 49: Neurostimulation Devices: List of Pipeline Products, 5, 2011 153

Table 50: Interventional Neurology: List of Pipeline Products, 1, 2011 157

Table 51: Interventional Neurology: List of Pipeline Products, 1, 2011 158

Table 52: Neurological Diagnostic Equipment: List of Pipeline Products, 1, 2011 161

Table 53: Neurological Diagnostic Equipment: List of Pipeline Products, 2, 2011 162

Table 54: Neurosurgical Products: List of Pipeline Products, 2011 164

Table 55: CSF Management: List of Pipeline Products, 2011 165

Table 56: Neurology Device Market, Mergers & Acquisitions, by Volume Global, 2007-2010 167

Table 57: Neurology Device Market, Mergers & Acquisitions, by Volume, Global, 2007-2010 169

Table 58: Neurology Device Market, Mergers & Acquisitions, by Volume, Global, 2007-2010 170



If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.